- Home
- / ENDRA Life Sciences
ENDRA Life Sciences
Stock Price
$0.3
2024-10-29
Market Capitalization
$5.9 M
2024-10-29
ENDRA Life Sciences Summary
Company Summary
- Overview
- ENDRA Life Sciences is a company that develops photo-acoustic ultrasound technologies. It offers a thermo-acoustic enhanced ultrasound (TAEUS) platform that enables clinicians to visualize human tissue composition, function, and temperature.
- Type
- Public
- Status
- Active
- Founded
- 2009
- HQ
- Ann Arbor, MI, US | view all locations
- Website
- https://endrainc.com
- Cybersecurity rating
Table of Contents
Key People
Steve Freeman, Human Resources Leader
Irina Pestrikova, Senior Director of Finance
Lou Basenese, Director
LocationsView all
5 locations detected
Ann Arbor, MI HQ
United States
3600 Green Court, Suite 350
Paris, IDF
France
183 Rue de Courcelles
Frankfurt, HE
Germany
Eschersheimer Landstraße 14
Amsterdam, NH
Netherlands
Basisweg 10
London, England
United Kingdom
1 Bartholomew Lane
ENDRA Life Sciences Financials
Summary Financials
- Net income (Q1, 2026)
- ($1.3M)
- Cash (Q1, 2026)
- $356.5K
- EBIT (Q1, 2026)
- ($2.2M)
- Enterprise value
- $6.0M